In an op-ed published in BioCentury Inc. May 14, Gigi Hirsch of NEWDIGS Initiative at Tufts Medical Center and Jane F. Barlow, MD, MPH, MBA of Real Endpoints make the case that the only way to have our cake (medical innovation) and to be able to eat it (afford the innovation) is to increase health efficiency – that is, capturing the full value of medical products.
read full article ›For the Real Endpoints team, Asembia Day 2 was chock-a-block with 1:1 conversations, panel discussions, and demos of RE Assist, our AI-based platform providing real-time intel of available financial support for patients. Caught in action: Susan Raiola explaining how RE Assist helps solve the Medicare copay dilemma; and Jeff Berkowitz, seen here with Bruce Japsen and Amazon's Laura Jensen, following a spirited panel discussion on the future of digital health, telehealth, and pharmacy.
read full article ›Asembia is hopping. Meetings are appropriately fueled by bread and chocolate - you know the staff of life! Some hot takes from the field,
read full article ›Healthcare information focused on the intersection of payers and product companies.
read full article ›Real Endpoints board member Michael Sherman provides the World Orphan Drug Congress audience with real world insights on what it takes to get transformative therapies reimbursed in today's environment.
read full article ›It's less than a week until Asembia's AXS24 Summit. If you are roaming the Wynn next week, you should really stop by Margaux 2 on Tuesday April 30th at 3:00pm to hear Real Endpoints' Jeff Berkowitz and Amazon's Laura Jensen talk Pharmacy 2.0, digital health, and the evolution of hashtag#telehealth with Bruce Japsen. The forty minute session is going to fly by.
read full article ›It was an honor (and very intimidating!) to share a stage with Nobel laureates and Pulitzer prize winners at this week’s hashtag#ABI24 (Accelerating Bio-Innovation) meeting at the Wellcome Genome Campus in Cambridge, UK. Market access hurdles can be a head scratcher for even the brightest scientific minds. Thank you to Royalty Pharma for inviting me to share my views! https://abiconference.com/
read full article ›Curious about prescription digital therapeutics and what's required for payer coverage. Our colleague Rob O'Brien will be in Nawlins next week for AMCP 2024. Laissez les bons temps rouler!
read full article ›Asembia24 is less than one month away. Don't gamble with your market access needs. Connect with the Real Endpoints team: Jeff Berkowitz, Susan Raiola, Rob O'Brien, Ryan Walsh, and Jeff Parish. We'll be on the ground in Las Vegas starting April 28.
read full article ›There's been much discussion about just how much impact lowering of out-of-pocket maximums, a major feature of the Part D redesign, will have on patient affordability. Data from RE Assist, our AI-based platform that identifies and validates new sources of copay and deductible foundation support, suggests that even with lower OOP maximums, patients will continue struggle to afford their meds.
read full article ›